Institutional Ownership Cara Therapeutics, Inc. (CARA)
This table provides information about the institutional ownership of Cara Therapeutics, Inc. (CARA). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 797,487 shares, which have been reported (via 13F filing form) to have a value of $12.7 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
744,707
shares
|
$11.9 Million
0.0% of portfolio
|
Q2 2024
Reduced 78.23%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
40,425
shares
|
$645,183
0.02% of portfolio
|
Q2 2020
Reduced 0.29%
|
|
|
Rothschild Investment Corp
|
Oct 16, 2023 Q3 2023 |
10,600
shares
|
$169,176
0.0% of portfolio
|
Q3 2023
Reduced 29.8%
|
|
|
Ahrens Investment Partners LLC
|
Apr 21, 2023 Q1 2023 |
700
shares
|
$11,172
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Benjamin F. Edwards & Company, Inc.
St. Louis, MO |
Aug 12, 2024 Q2 2024 |
500
shares
|
$7,980
0.0% of portfolio
|
Q3 2021
Added 66.67%
|
|
|
Fin Trust Capital Advisors, LLC
|
Oct 11, 2024 Q3 2024 |
260
shares
|
$4,149
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
First Capital Advisors Group, Llc.
Little Silver, NJ |
Aug 15, 2023 Q2 2023 |
175
shares
|
$2,793
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Fieldpoint Private Securities, LLC
|
Aug 05, 2022 Q2 2022 |
120
shares
|
$1,915
0.0% of portfolio
|
Q1 2022
New holding
|